A Study to Determine the Bioequivalence of an Oral Formulation of Topotecan Containing the Drug Substance Manufactured by New Process Relative to the Current Study Formulation of Topotecan in Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 10 Mar 2011
At a glance
- Drugs Topotecan (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 01 Mar 2009 Results have been published in the International Journal of Clinical Pharmacology and Therapeutics.
- 28 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 02 Jul 2007 Status changed from recruiting to in progress.